<DOC>
	<DOCNO>NCT00270153</DOCNO>
	<brief_summary>Chronic allograft nephropathy ( CAN ) lead cause longterm renal transplant loss . Angiotensin-II may play role development progression CAN . Angiotensin convert enzyme inhibitor ( ACEI ) comprise drug class inhibit effect angiotensin-II . However drug report cause elevate potassium creatinine level renal transplant patient . Yet , several retrospective report long term benefit improve renal function graft survival renal transplant recipient . There report prospective randomize controlled trial ACEI renal transplant patient early post transplant period . The purpose present study ass safety enalapril , drug ACEI class , start 1-3 month post transplant . This double-blinded , randomize control trial enalapril vs. placebo new renal transplant patient serum creatinine value higher 2.5mg/dl normal serum potassium level . The study drug administer 6 month . Patients monitor renal transplant clinic every 1-4 week accord routine protocol . Clinical end-points occurence potassium &gt; 5.9mEQ/L sustained increase serum creatinine &gt; 50 % baseline .</brief_summary>
	<brief_title>The Use ACE Inhibitors Early Renal Post-transplant Period</brief_title>
	<detailed_description>All new renal transplant recipient function allograft serum creatinine le 2.6 mg/dl within first 3 month post transplant would eligible study safety enalapril 5 mg v placebo . Patients serum potassium persistently 5.5 mEQ/L would exclude . This double-blinded randomize control study . End-points study persistent rise serum creatinine &gt; 50 % baseline otherwise explain clinical evaluation , persistent serum potassium &gt; 5.9mEQ/L . Study duration 6 month . At end study patient continue ACEI clinically stable</detailed_description>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<criteria>new adult renal transplant recipient good renal function define serum creatinine le 2.6 mg/dl , normal serum potassium level , contraindication ACE inhibitor use . renal transplant patient persistent serum creatinine level 2.5 mg/dl , hyperkalemia serum potassium level 5.5 mEQ/dl , history allergic reaction ACE inhibitor angiotensin receptor blocker , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>renal transplant , ACE inhibitor</keyword>
</DOC>